{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:56:31Z","timestamp":1790988991951,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000303","name":"Inspire Foundation","doi-asserted-by":"publisher","award":["2020\/IF200368"],"award-info":[{"award-number":["2020\/IF200368"]}],"id":[{"id":"10.13039\/501100000303","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/1125(0018)\/2021-EMR-I"],"award-info":[{"award-number":["09\/1125(0018)\/2021-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008628","name":"Ministry of Electronics and Information technology","doi-asserted-by":"publisher","award":["4(16)\/2019-ITEA"],"award-info":[{"award-number":["4(16)\/2019-ITEA"]}],"id":[{"id":"10.13039\/501100008628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168428","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:23:34Z","timestamp":1787390614000},"page":"168428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing Nelfinavir: AIM2 inflammasome-associated anti-tumor effects in Glioblastoma"],"prefix":"10.1016","volume":"1873","author":[{"given":"Durgesh","family":"Meena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Chhipa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bbadis.2026.168428_bb0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"6","key":"10.1016\/j.bbadis.2026.168428_bb0010","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","article-title":"Glioblastoma: pathology, molecular mechanisms and markers","volume":"129","author":"Aldape","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168428_bb0015","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1016\/S1470-2045(24)00190-6","article-title":"A brave new framework for glioma drug development","volume":"25","author":"Hotchkiss","year":"2024","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.6004\/jnccn.2023.0002","article-title":"NCCN Guidelines\u00ae Insights: central nervous system cancers, version 2.2022","volume":"21","author":"Horbinski","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168428_bb0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168428_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113437","article-title":"The anti-cancer properties of the HIV protease inhibitor nelfinavir","volume":"12","author":"Subeha","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.bbadis.2026.168428_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163949","article-title":"The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review","volume":"13","author":"Rascio","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.bbadis.2026.168428_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155970","article-title":"Oxidative stress mediates the antiproliferative effects of nelfinavir in breast cancer cells","volume":"11","author":"Soprano","year":"2016","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.bbadis.2026.168428_bb0045","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-05-1220","article-title":"HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo","volume":"65","author":"Gupta","year":"2005","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168428_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1349-7006.2005.00063.x","article-title":"HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling","volume":"96","author":"Yang","year":"2005","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168428_bb0055","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/0008-5472.CAN-06-3377","article-title":"HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest","volume":"67","author":"Jiang","year":"2007","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.bbadis.2026.168428_bb0060","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1158\/0008-5472.CAN-07-0796","article-title":"HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress","volume":"67","author":"Pyrko","year":"2007","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168428_bb0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1593\/neo.06535","article-title":"HIV protease inhibitors decrease VEGF\/HIF-1\u03b1 expression and angiogenesis in glioblastoma cells","volume":"8","author":"Pore","year":"2006","journal-title":"Neoplasia"},{"issue":"32","key":"10.1016\/j.bbadis.2026.168428_bb0070","doi-asserted-by":"crossref","first-page":"E4671","DOI":"10.1073\/pnas.1602419113","article-title":"AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity","volume":"113","author":"Di Micco","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168428_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni.1702","article-title":"An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome","volume":"10","author":"B\u00fcrckst\u00fcmmer","year":"2009","journal-title":"Nat. Immunol."},{"issue":"23","key":"10.1016\/j.bbadis.2026.168428_bb0080","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1007\/s00018-016-2296-9","article-title":"Absent in melanoma 2 proteins in the development of cancer","volume":"73","author":"Choubey","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2026.168428_bb0085","series-title":"Cloning a Novel Member of the Human Interferon-inducible Gene Family Associated With Control of Tumorigenicity in a Model of Human Melanoma","author":"Deyoung","year":"1997"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168428_bb0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.yexcr.2018.07.021","article-title":"AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction","volume":"370","author":"Chai","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2026.168428_bb0095","article-title":"Loss of AIM2 expression promotes hepatocarcinoma progression through activation of MTOR-S6K1 pathway","volume":"7","author":"Ma","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bbadis.2026.168428_bb0100","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/emmm.201201569","article-title":"Tumour inflammasome-derived IL-1\u03b2 recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma","volume":"4","author":"Chen","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168428_bb0105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1349-7006.2012.02211.x","article-title":"Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation","volume":"103","author":"Kondo","year":"2012","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168428_bb0110","doi-asserted-by":"crossref","first-page":"20161","DOI":"10.1002\/jcp.28617","article-title":"AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168428_bb0115","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm.3908","article-title":"Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168428_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11060-019-03230-y","article-title":"Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme","volume":"144","author":"Chen","year":"2019","journal-title":"J. Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168428_bb0125","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3324\/haematol.2015.135780","article-title":"Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65\/08)","volume":"101","author":"Driessen","year":"2016","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.bbadis.2026.168428_bb0130","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2007.15.2355","article-title":"Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer","volume":"26","author":"Brunner","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168428_bb0135","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jamaoncol.2019.2095","article-title":"Clinical outcomes of the HIV protease inhibitor Nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA\/IIIB non-small cell lung cancer: a phase 1\/2 trial","volume":"5","author":"Rengan","year":"2019","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168428_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-013-1303-3","article-title":"A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme","volume":"116","author":"Alonso-Basanta","year":"2014","journal-title":"J. Neuro-Oncol."},{"issue":"162","key":"10.1016\/j.bbadis.2026.168428_bb0145","doi-asserted-by":"crossref","DOI":"10.3791\/61438-v","article-title":"Obtaining human microglia from adult human brain tissue","volume":"2020","author":"Agrawal","year":"2020","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0150","article-title":"Differential expression profile of NLRs and AIM2 in glioma and implications for NLRP12 in glioblastoma","volume":"9","author":"Sharma","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101968","article-title":"Dopamine induces functional extracellular traps in microglia","volume":"24","author":"Agrawal","year":"2021","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01671-2","article-title":"RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway","volume":"39","author":"Xu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168428_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2026.153924","article-title":"A microphysiological spheroid system for modeling glioblastoma structure and therapy response","volume":"825","author":"Ray","year":"2026","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2026.168428_bb0170","series-title":"Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma Pathophysiology","author":"Meena","year":"2024"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168428_bb0175","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1039\/C4BM00319E","article-title":"Media additives to promote spheroid circularity and compactness in hanging drop platform","volume":"3","author":"Leung","year":"2015","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BCJ20200710","article-title":"Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids","volume":"478","author":"Pinto","year":"2021","journal-title":"Biochem. J."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168428_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044640","article-title":"Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay","volume":"7","author":"Ho","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbadis.2026.168428_bb0190","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1086\/515312","article-title":"A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)-1 Protease, to Treat HIV Infection","volume":"177","author":"Markowitz","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168428_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155970","article-title":"Oxidative stress mediates the antiproliferative effects of nelfinavir in breast cancer cells","volume":"11","author":"Soprano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2026.168428_bb0200","series-title":"Invited Review Three-Dimensional Cell Cultures: From Molecular Mechanisms to Clinical Applications","author":"Mueller-Klieser","year":"1997"},{"issue":"9\u201310","key":"10.1016\/j.bbadis.2026.168428_bb0205","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/biot.200700228","article-title":"Recent advances in three-dimensional multicellular spheroid culture for biomedical research","volume":"3","author":"Lin","year":"2008","journal-title":"Biotechnol J."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168428_bb0210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00441-005-0148-2","article-title":"Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and \u03b21-integrin","volume":"324","author":"Lin","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbadis.2026.168428_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-4-12","article-title":"Establishment and characterization of multicellular spheroids from a human glioma cell line; implications for tumor therapy","volume":"4","author":"Khaitan","year":"2006","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168428_bb0220","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bioorg.2019.02.010","article-title":"Novel lawsone-containing ruthenium(II) complexes: synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells","volume":"85","author":"De Grandis","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0225","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11033-020-06109-8","article-title":"Anthracycline-induced cytotoxicity in the GL261 glioma model system","volume":"48","author":"Tavener","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168428_bb0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/15368378.2018.1477052","article-title":"Cytotoxicity of carboplatin on human glioblastoma cells is reduced by the concomitant exposure to an extremely low-frequency electromagnetic field (50\u00a0Hz, 70\u00a0G)","volume":"37","author":"Amiri","year":"2018","journal-title":"Electromagn. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168428_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin\u2014an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168428_bb0245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/1973947812Y.0000000011","article-title":"Antitumour effects of a protease inhibitor, nelfinavir, in hepatocellular carcinoma cancer cells","volume":"24","author":"Sun","year":"2012","journal-title":"J. Chemother."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168428_bb0250","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.bjc.6603435","article-title":"NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines","volume":"95","author":"Yang","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbadis.2026.168428_bb0255","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1101\/pdb.prot087288","article-title":"Quantitation of apoptosis and necrosis by annexin V binding, propidium iodide uptake, and flow cytometry","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168428_bb0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08916930701356978","article-title":"HMGB1: a signal of necrosis","volume":"40","author":"Raucci","year":"2007","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hep.28893","article-title":"Redox-dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice","volume":"65","author":"Sun","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.bbadis.2026.168428_bb0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/boc.202000160","article-title":"Role of A- and B-type lamins in nuclear structure\u2013function relationships","volume":"113","author":"Patil","year":"2021","journal-title":"Biol. Cell."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168428_bb0275","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","article-title":"Human monocytes engage an alternative inflammasome pathway","volume":"44","author":"Gaidt","year":"2016","journal-title":"Immunity"},{"issue":"7237","key":"10.1016\/j.bbadis.2026.168428_bb0280","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43691-4","article-title":"Assembly mechanism of the inflammasome sensor AIM2 revealed by single molecule analysis","volume":"14","author":"Sharma","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168428_bb0290","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab. Investig."},{"issue":"15","key":"10.1016\/j.bbadis.2026.168428_bb0295","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1158\/1078-0432.CCR-10-0705","article-title":"GDF-15 contributes to proliferation and immune escape of malignant gliomas","volume":"16","author":"Roth","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168428_bb0300","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ijc.29380","article-title":"Paracrine regulation of glioma cells invasion by astrocytes is mediated by glial-derived neurotrophic factor","volume":"137","author":"Shabtay-Orbach","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010102","article-title":"Autophagy in the immunosuppressive perivascular microenvironment of glioblastoma","volume":"12","author":"Molina","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0310","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168428_bb0315","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.celrep.2018.03.105","article-title":"Glioblastoma model using human cerebral organoids","volume":"23","author":"Ogawa","year":"2018","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168428_bb0320","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0325","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbcan.2013.04.003","article-title":"Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies","volume":"1836","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0330","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2009.02.033","article-title":"A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line","volume":"281","author":"Hua","year":"2009","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168428_bb0335","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1158\/2159-8290.CD-11-0109","article-title":"A molecularly annotated platform of patient-derived xenografts (\u201cxenopatients\u201d) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer","volume":"1","author":"Bertotti","year":"2011","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168428_bb0340","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168428_bb0345","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ng.3967","article-title":"Patient-derived xenografts undergo mouse-specific tumor evolution","volume":"49","author":"Ben-David","year":"2017","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0350","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0355","article-title":"Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors","volume":"12","author":"Chen","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168428_bb0360","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/glia.22446","article-title":"Bioactive 3D cell culture system minimizes cellular stress and maintains the in vivo-like morphological complexity of astroglial cells","volume":"61","author":"Puschmann","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.bbadis.2026.168428_bb0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2015.02.025","article-title":"Three-dimensional culture conditions differentially affect astrocyte modulation of brain endothelial barrier function in response to transforming growth factor \u03b21","volume":"1608","author":"Hawkins","year":"2015","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168428_bb0370","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12195-021-00691-y","article-title":"The impact of astrocytes and endothelial cells on glioblastoma stemness marker expression in multicellular spheroids","volume":"14","author":"Nakod","year":"2021","journal-title":"Cell. Mol. Bioeng."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168428_bb0375","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/neuonc\/noae237","article-title":"Glioma\u2013astrocyte connexin43 confers temozolomide resistance through activation of the E2F1\/ERCC1 axis","volume":"27","author":"Gui","year":"2025","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168428_bb0380","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3892\/mmr.2015.4680","article-title":"Astrocytes protect glioma cells from chemotherapy and upregulate survival genes via gap junctional communication","volume":"13","author":"Lin","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2026.168428_bb0385","series-title":"Role of ABC Transporters in the Chemoresistance of Human Gliomas","volume":"Vol 6","author":"Decl\u00e8ves","year":"2006"},{"issue":"13","key":"10.1016\/j.bbadis.2026.168428_bb0390","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/cncr.33449","article-title":"Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer","volume":"127","author":"Garcia-Soto","year":"2021","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168428_bb0395","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/JTO.0b013e3182435aa6","article-title":"A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA\/IIIB non-small cell lung cancer: a report of toxicities and clinical response","volume":"7","author":"Rengan","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168428_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13040874","article-title":"Organoid and spheroid tumor models: techniques and applications","volume":"13","author":"Gunti","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168428_bb0405","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168428_bb0410","first-page":"11","article-title":"Patient-derived cancer organoids as predictors of treatment response","author":"Verduin","year":"2021","journal-title":"Front Oncol."},{"issue":"21","key":"10.1016\/j.bbadis.2026.168428_bb0415","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","article-title":"Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas","volume":"68","author":"Jones","year":"2008","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168428_bb0420","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.bbadis.2026.168428_bb0425","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:19:00Z","timestamp":1790986740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926002942"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168428","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing Nelfinavir: AIM2 inflammasome-associated anti-tumor effects in Glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168428"}}